Jazz Pharmaceutical
4 known investors
Find your way into Jazz Pharmaceutical
Sign up to see every warm intro you have to Jazz Pharmaceutical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Jazz Pharmaceutical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers. It serves patients with high unmet medical needs in rare disease and rare cancer areas.
Investors · 4
Longitude Capitallisted by Longitude CapitalMenlo Park · $10M – $30M
How we know: Longitude Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Founder mafia
4 people who came through Jazz Pharmaceutical went on to found or lead other companies.
Frequently asked questions
- What does Jazz Pharmaceutical do?
- Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers. It serves patients with high unmet medical needs in rare disease and rare cancer areas.
- Who are Jazz Pharmaceutical's investors?
- Jazz Pharmaceutical's investors include Longitude Capital, Prospect Venture Partners, Rex Health Ventures, Solas BioVentures.






